Dec 13, 2011 by Dave Williamson3 Biotechs Making Big Moves on Big NewsTrial results and FDA panels ruled the health-care sector today.
Dec 9, 2011 by Dave Williamson1 Biotech Soars While Another CrashesCell Therapeutics dilutes shareholders while SIGA squashes fears.
Nov 30, 2011 by Dave WilliamsonHealth Care's 5 Worst November FlopsThese stocks had a terrible month.
Nov 28, 2011 by Dave Williamson5 Biotechs Posting Big GainsThe daily health-care news investors need to read.
Nov 22, 2011 by Dave WilliamsonFrontline Investors: Why Shares Are Tanking 40%Rumors of a restructuring cut shares nearly in half.
Nov 21, 2011 by Dave WilliamsonPharmasset Acquired, Shares Jump 85%Gilead Sciences buys Pharmasset and hepatitis C drug PSI-7977.
Nov 21, 2011 by Dave WilliamsonMarket Volatility = Biotech OpportunityGilead buys Pharmasset, Spectrum gets a break, and Eylea's approved.
Nov 16, 2011 by Dave Williamson3 Biotechs Beating the MarketThe daily health-care news investors need to read.
Nov 16, 2011 by Dave WilliamsonDon't Get Too Worked Up Over Enterprise Products Partners' EarningsAll cash flow is not created equal.
Nov 12, 2011 by Dave WilliamsonThese 2 Biotechs Got CrushedHighlighting the day's health-care stories critical to investors.
Nov 11, 2011 by Dave WilliamsonRoundtable: 5 Must-Watch StocksHighlighting companies Fools are watching around the office.
Nov 9, 2011 by Dave WilliamsonMarket Crash = Biotech CarnageHighlighting the day's health-care stories critical to investors.
Nov 8, 2011 by Dave WilliamsonBiotech Pops, Drops, and Break-UpsHighlighting the day's health-care stories critical to investors.
Nov 7, 2011 by Dave WilliamsonHealth-Care News You Can't Afford to MissHighlighting the day's health-care stories critical to investors.
Nov 5, 2011 by Dave WilliamsonInhibitex Investors: Why Shares Popped 115%Great results for INX-189 send shares skyward.
Nov 3, 2011 by Dave WilliamsonMedivation Investors: Why Your Stock Just Jumped 140%Medivation shares pop on trial success for prostate cancer treatment MDV3100.
Nov 2, 2011 by Dave WilliamsonAfter Hours: Dendreon's Shares Crushed AgainBad guidance in Q3 earnings punishes this stock.
Sep 30, 2011 by Dave Williamson4 Health-Care Stocks Worth WatchingFour companies our Fools are watching ahead of earnings.
